Skip to content
Independent analysis of NHS open data
PharmaInsight

Tolterodine 4mg modified-release capsules

0704020N0AAACAC · Obstetrics, Gynaecology and Urinary-Tract Disorders
Data updated May 2026
10,864items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£144,017

Net ingredient cost · May 2026

NHSBSA PCA

115,141items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Tolterodine 4mg modified-release capsules: national items dispensed by month

0 6k 12k Jan 2021 Aug 2021 Mar 2022 Oct 2022 May 2023 Oct 2025 May 2026 10,864 Jan 2021: 10k Feb 2021: 9k Mar 2021: 11k Apr 2021: 10k May 2021: 10k Jun 2021: 10k Jul 2021: 10k Aug 2021: 10k Sep 2021: 10k Oct 2021: 10k Nov 2021: 10k Dec 2021: 10k Jan 2022: 9k Feb 2022: 9k Mar 2022: 10k Apr 2022: 9k May 2022: 10k Jun 2022: 9k Jul 2022: 9k Aug 2022: 9k Sep 2022: 9k Oct 2022: 9k Nov 2022: 9k Dec 2022: 9k Jan 2023: 9k Feb 2023: 8k Mar 2023: 9k Apr 2023: 8k May 2023: 9k Jun 2023: 9k May 2025: 11k Jun 2025: 8k Jul 2025: 7k Aug 2025: 9k Sep 2025: 8k Oct 2025: 8k Nov 2025: 9k Dec 2025: 11k Jan 2026: 11k Feb 2026: 10k Mar 2026: 11k Apr 2026: 12k May 2026: 11k

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Tolterodine. See the chemical for the full national picture and related presentations.

Top dispensing practices

Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).